SynthesisRenal failure2025

Comparative efficacy and safety of febuxostat and allopurinol in chronic kidney disease stage 3-5 patients with asymptomatic hyperuricemia: a network meta-analysis.

Jiaojiao Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.